Humanetics Corp. (with funding from NIAID) is sponsoring a clinical trial to evaluate the effectiveness and safety of BIO 300 to prevent long-term lung injury in previously hospitalized COVID-19 patients, and provide researchers a better understanding of COVID / Long COVID associated lung injury. Register HERE
This is a great opportunity to receive a series of medical tests at no cost, while contributing to the development of a potential therapy to improve lung function.
Study sites: New York, Denver, Houston.
Trial is 12 weeks, with 5 clinic and 4 telehealth visits over a one year period.
